HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): William D. Bolton David C. Rice Wayne Hofstetter Reza Mehran Jack A. Roth Stephen G. Swisher Ara A. Vaporciyan Garrett L. Walsh Permission Requests Google Scholar Articles by Bolton, W. D. Articles by Rhines, L. PubMed Articles by Bolton, W. D. Articles by Rhines, L. Related Collections Lung - cancer Chest wall

J Thorac Cardiovasc Surg 2009;137:1379-1387
© 2009 The American Association for Thoracic Surgery

General Thoracic Surgery

Superior sulcus tumors with vertebral body involvement: A multimodality approach

^a Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Tex
^b Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Tex
^c Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Tex
^d Department of Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Tex
^e Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Tex

Received for publication May 9, 2008; revisions received November 24, 2008; accepted for publication January 28, 2009.

^_* Address for reprints: David C. Rice, MD, Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Box 445, Houston, TX 77030. (Email: drice{at}mdanderson.org).

Objective: Superior sulcus tumors with involvement of the spine have historically been considered unresectable. We have previously documented a 2-year survival of 54% in patients treated with a multimodality approach. This work builds on our previous experience and examines the long-term outcomes.

Methods: A retrospective review was performed on patients with superior sulcus non–small cell lung cancer tumors with involvement of the vertebral column (n = 39) treated at The University of Texas MD Anderson Cancer Center from 1990 to 2006. Their clinical and pathologic data were analyzed for short- and long-term outcomes.

Results: Group 1 included 8 (21%) patients with neuroforamen or transverse process involvement, group 2 had 16 (41%) patients with partial vertebrectomy, and group 3 had 15 (38%) patients with total vertebrectomy. There were 2 (5%) postoperative deaths, and 11 (28%) patients had major complications. Margins were positive in 17 (44%) patients. Recurrence occurred in 23 (59%) patients and was local in 11 (28%) patients, distant in 11 (28%) patients, and both in 1 (3%) patient. Median time to local recurrence was 7 months in patients with positive margins and has not been reached for patients with negative margins (P = .007). Median, 2-year, and 5-year overall survival was 18 months, 47%, and 27%, respectively. On multivariate analysis, the only independent predictor of shorter survival was nodal metastases (P = .001; hazard ratio, 6.5; 95% confidence interval, 2.2–19.2).

Conclusion: An aggressive multimodality approach involving surgical resection can be performed with acceptable morbidity in highly selected patients with superior sulcus tumors and vertebral invasion at a specialized center. Encouraging long-term survival can be achieved in patients with negative margins and no lymph node involvement.